These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9675963)

  • 1. [Dissolution of acute stent thrombosis by abciximab bolus].
    Russo G; Nicosia A; Tamburino C; Mammana C; Galassi AR; Monaco A; Grassi R; Calvi V; Giuffrida G
    Cardiologia; 1998 Jun; 43(6):631-4. PubMed ID: 9675963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease.
    Kim W; Jeong MH; Hong YJ; Lee SH; Park WS; Kim JH; Kim IS; Choi MJ; Ahn YK; Cho JG; Park JC; Cho DL; Kim H; Kang JC
    Korean J Intern Med; 2004 Dec; 19(4):220-9. PubMed ID: 15683110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of platelet glycoprotein IIb/IIIa inhibitors in coronary stenting for reconstruction of complex lesions: procedural and 30 day outcome.
    Galassi AR; Russo G; Nicosia A; Tamburino C; Foti R; Rodi G; Calvi V; Gulizia G; Distefano G; Moshiri S; Giuffrida G
    Cardiologia; 1999 Jul; 44(7):639-45. PubMed ID: 10476589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of abciximab (Reopro) in the catheterization laboratory and in unstable coronary syndromes].
    Banai S; Keren A; Daniel N; Benhorin J
    Harefuah; 1999 Jan; 136(1):29-34, 95, 94. PubMed ID: 10914155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
    Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
    Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet IIb/IIIa antagonists followed by delayed stent implantation. A new treatment for vein graft lesions containing massive thrombus.
    Robinson N; Barakat K; Dymond D
    Heart; 1999 Apr; 81(4):434-7. PubMed ID: 10092575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anti-GP IIb-IIIa in acute thrombosis after intracoronary stent implantation.
    Henry P; Boughalem K; Rinaldi JP; Makowski S; Khalife K; Guermonprez JL; Blanchard D
    Cathet Cardiovasc Diagn; 1998 Jan; 43(1):105-7. PubMed ID: 9473205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial.
    Valgimigli M; Campo G; Percoco G; Bolognese L; Vassanelli C; Colangelo S; de Cesare N; Rodriguez AE; Ferrario M; Moreno R; Piva T; Sheiban I; Pasquetto G; Prati F; Nazzaro MS; Parrinello G; Ferrari R;
    JAMA; 2008 Apr; 299(15):1788-99. PubMed ID: 18375998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.
    Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A
    Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.
    Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L;
    N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era.
    Adelman AG; Caramori PR; Cohen EA; Chisholm RJ; Côté G; Ducas J; O'Neill BJ; Tcheng JE
    Can J Cardiol; 1998 Aug; 14(8):1057-66. PubMed ID: 9738165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trial.
    Cho L; Marso SP; Bhatt DL; Topol EJ
    J Womens Health Gend Based Med; 2000 Sep; 9(7):741-6. PubMed ID: 11025866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of abciximab for treatment of early coronary artery stent thrombosis.
    Casserly IP; Hasdai D; Berger PB; Holmes DR; Schwartz RS; Bell MR
    Am J Cardiol; 1998 Oct; 82(8):981-5. PubMed ID: 9794358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury.
    Bright JM; Dowers K; Powers BE
    Vet Ther; 2003; 4(1):35-46. PubMed ID: 12756634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instant dissolution of intracoronary thrombus by abciximab.
    Lee CH; Ho KT; Tan HC
    Int J Cardiol; 2005 Sep; 104(1):102-3. PubMed ID: 16137518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
    Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
    N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheolytic thrombectomy: a new treatment for stent thrombosis.
    Scott LR; Silva JA; White C; Collins TJ
    Catheter Cardiovasc Interv; 1999 May; 47(1):97-101. PubMed ID: 10385170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of the platelet glycoprotein IIb/IIIa inhibitor abciximab in Chinese patients undergoing high-risk angioplasty.
    Chen YH; Chen JW; Wu TC; Ding PY; Wang SP; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan; 63(1):8-15. PubMed ID: 10645045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.